申请人:Pfizer Inc.
公开号:US04725616A1
公开(公告)日:1988-02-16
1,3-Dicarboxamidooxindoles as antiinflammatory agents prepared by reaction of the 1-carbamoyloxindole with an isocyanate or by aminolysis of the corresponding alkyl 1-carbamoyloxindole-3-carboxylate.
1,3-二羧酰胺基
吲哚作为抗炎药物,通过1-羰胺氧
吲哚与
异氰酸酯的反应或通过相应的烷基1-羰胺氧
吲哚-3-
羧酸酯的
氨解反应制备。